Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

29
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between the Japanese Version of Montreal Cognitive Assessment Tasks and Driving as the Primary Mode of Transport Among Community-Dwelling Older Adults.

Canadian geriatrics journal : CGJ·2026
Same author

Effects of exercise intervention according to functional decline risk before and after the study among community-dwelling older adults.

The journal of medical investigation : JMI·2026
Same author

The Kihon Checklist is a useful screening tool for predicting sarcopenia:A retrospective cross-sectional pilot study.

The journal of medical investigation : JMI·2025
Same author

Clinical, Electrophysiologic, and Pathologic Features of Anti-Contactin-Associated Protein 1 Autoimmune Nodopathy.

Neurology·2025
Same author

Reduced phase angle as a potential indicator of mild cognitive impairment.

Journal of clinical biochemistry and nutrition·2025
Same author

How common is sarcopenia associated with frailty? Diagnosis using the Kihon Checklist.

The journal of medical investigation : JMI·2025

Related Experiment Video

Updated: May 2, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K

[Depression in Parkinson's disease].

Miho Murata1, Tomoko Okamoto

  • 1Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry.

Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|March 14, 2014
PubMed
Summary

Depression affects 30-40% of Parkinson's disease patients, worsening motor symptoms and quality of life. Treatment involves optimizing dopamine therapy, antiparkinsonian drugs, and therapies like CBT.

Area of Science:

  • Neurology
  • Psychiatry
  • Movement Disorders

Context:

  • Parkinson's disease (PD) is a neurodegenerative disorder.
  • Depression is a common comorbidity in PD, affecting 30-40% of patients.
  • Depression significantly impacts the quality of life (QOL) and functional status in PD.

Purpose:

  • To review the characteristics, impact, and management of depression in Parkinson's disease.
  • To highlight the unique features of depression in PD compared to major depression.
  • To discuss treatment strategies for depression in PD patients.

Summary:

  • Depression in PD negatively affects motor symptoms (tremors, gait) and rehabilitation engagement, independent of disease progression.
  • Unlike major depression, depression in PD rarely involves guilt, self-blame, or suicidal ideation.

More Related Videos

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.7K

Related Experiment Videos

Last Updated: May 2, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.7K
  • Depression can manifest across all stages of PD, with anxiety common in patients experiencing wearing-off symptoms.

    • Impact:

    • Optimizing dopamine replacement therapy is crucial for managing depression in PD.
    • Antiparkinsonian medications may offer dual benefits for motor and mood symptoms.
    • Cognitive Behavioral Therapy (CBT) and peer counseling are identified as beneficial non-pharmacological interventions.